MARTECH
DEAD

Serial Number

78550990

Owner

Selexis S.A.

Attorney

Joyce H. A. von Natzmer, Esquire

Filing Date

Jan 20, 2005

Add to watchlist:

No watchlists yet
View on USPTO

MARTECH Trademark

Serial Number: 78550990

MARTECH is a trademark filed by Selexis S.A. on January 20, 2005. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Selexis S.A. (3 trademarks)

Plan-les-Ouates 1228 , CH

Entity Type: 99

Trademark Details

Filing Date

January 20, 2005

Registration Date

Not Registered

Goods & Services

Reagents, chemicals and preparations for gene analysis, for molecular biological reaction analysis and for intercellular interaction analysis, DNA, proteins, products manufactured through biotechnological methods, mammalian cell lines producing or expressing recombinant proteins, expression vectors

Biotechnology information services, Biotechnology research, Providing of information with regard to molecular biology, biochemistry and biotechnology, Analysis and research services in the field of molecular biology, biochemistry and biotechnology, Synthesis of oligonucleotides and other biological active molecules for biotechnology research and related analysis, Technical consultation and research in the field of biotechnology and drug discovery, Services in the field of molecular biology, biotechnology, microbiology, food technology and environmental technology, Medical, pharmaceutical, scientific, pharmacological, genetic, diagnostic, therapeutic and biotechnology research and development services, Providing temporary use of an on-line, non-downloadable software featuring information on sequence motifs for use in the field of biotechnology, scientific and industrial research and consultancy, particularly in the field of human and veterinary medicine, pharmacology, molecular biology, biotechnology, microbiology, Research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields, computer services, namely, providing access to databases of life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology, Research consulting services, namely, research, development, validation, testing, data analysis and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 19, 2007 TCCA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 24, 2006 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 24, 2006 ABN2
NON-FINAL ACTION MAILED
Aug 26, 2005 CNRT
NON-FINAL ACTION WRITTEN
Aug 26, 2005 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2005 DOCK
NEW APPLICATION ENTERED
Jan 31, 2005 NWAP